共 89 条
[1]
Prakash G(2012)B cell non-Hodgkin’s lymphoma: experience from a tertiary care cancer center Ann Hematol 91 1603-1611
[2]
Sharma A(2020)Clinicopathological features of primary central nervous system diffuse large B cell lymphoma: experience from a Tertiary Center in North India Surg Neurol Int 11 424-1649
[3]
Raina V(2016)The role of autologous stem cell transplantation in primary central nervous system lymphoma Blood 127 1642-3979
[4]
Kumar L(2013)Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome J Clin Oncol 31 3971-S280
[5]
Sharma MC(2018)Clinicopathological characteristics and outcome in patients of primary CNS lymphoma treated with modified de-angelis protocol: an audit Clin Lymphoma Myeloma Leuk 18 S279-305
[6]
Mohanti BK(2012)Methotrexate induced lung injury in a patient with primary CNS lymphoma: a case report Mediterr J Hematol Infect Dis 4 201-703
[7]
Radotra BD(1971)The variability of individual tolerance to methotrexate in cancer patients Br J Cancer 25 289-903
[8]
Parkhi M(2006)Understanding and managing methotrexate nephrotoxicity Oncologist 11 694-121
[9]
Chatterjee D(2009)Primary central nervous system lymphoma: a profile of 26 cases from western India Neurol India 57 756-3068
[10]
Yadav BS(2004)Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide Neurology 63 901-e259